Skip to main
KTTA
KTTA logo

KTTA P/E Ratio

P/E Ratio as of Jun 13, 2025: -0.07

Average-0.0855
Median-0.0900
Minimum-0.0900
Maximum-0.0700
-0.07
Past Month+0.01 (12.50%)
The P/E ratio for KTTA is -0.07 as of Jun 13, 2025. This represents a decrease of -66.67% compared to its 12-month average P/E ratio of -0.21. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.

Pasithea Therapeutics Corp P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)

Pasithea Therapeutics Corp’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Pasithea Therapeutics Corp to industry peers.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

KTTA P/E Ratio Historic Data

DateStock priceP/E ratio
Jun 2, 2025$0.93-0.09
May 1, 2025$1.52-0.12
Apr 1, 2025$1.24-0.10
Mar 3, 2025$1.10-0.07
Feb 3, 2025$2.12-0.14
Jan 2, 2025$2.93-0.19

KTTA End of Year P/E Ratio

DateP/E ratioChange
2025-0.07-66.67%
2024-0.21-65.00%
2023-0.60-69.39%
2022-1.96-79.98%
2021-9.79

FAQs About Pasithea Therapeutics Corp (KTTA) P/E ratio

The latest P/E ratio of KTTA is -0.07, as of Jun 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).

Pasithea Therapeutics Corp’s last 12-month average P/E ratio is -0.21, compared to its current P/E ratio of -0.07. This reflects a decrease of -66.67%.

Pasithea Therapeutics Corp’s current P/E ratio of -0.07 is lower than its last 12-month average P/E of -0.21. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.

Pasithea Therapeutics Corp’s average P/E ratio over the last 3 years is -1.05. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.

Pasithea Therapeutics Corp’s average P/E ratio over the last 5 years is -1.45. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.

Pasithea Therapeutics Corp (KTTA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.